Letizia Pruccoli

Dr. Letizia Pruccoli

Department for Life Quality Studies, University of Bologna, 40126 Bologna, Italy
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2018 in Molecules
Verified
Journal Article
Open access
PDF file
MSMatheus de Freitas Silva
Matheus de Freitas Silva
Letizia PruccoliLetizia Pruccoli
Letizia Pruccoli
FMFabiana Morroni
Fabiana Morroni
GSGiulia Sita
Giulia Sita
FSFrancesca Seghetti
Francesca Seghetti
Andrea TarozziAndrea Tarozzi
Andrea Tarozzi
Chalcones have shown a broad spectrum of biological activities with clinical potential against various diseases. The biological activities are mainly attributed to the presence in the chalcones of the α,β-unsaturated carbonyl system, perceived as a potential Michael acceptor. Chalcones could activate the Kelch-like ECH-associated protein 1 (Keap1)/Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway through a Michael addition reaction with the cysteines of Keap1, which acts as a redox sensor and negative regulator of Nrf2. This modification allows the dissociation of Nrf2 from the cytoplasmic complex with Keap1 and its nuclear translocation. At this level, Nrf2 binds to the antioxidant response element (ARE) and activates the expression of several detoxification, antioxidant and anti-inflammatory genes as well as genes involved in the clearance of damaged proteins. In this regard, the Keap1/Nrf2–ARE pathway is a new potential pharmacological target for the treatment of many chronic diseases. In this review we summarize the current progress in the study of Keap1/Nrf2–ARE pathway activation by natural and synthetic chalcones and their potential pharmacological applications. Among the pharmacological activities highlighted, anti-inflammatory activity was more evident than others, suggesting a multi-target Michael acceptor mechanism for the chalcones involving key regulators of the Nrf2 and nuclear factor- κB (NF-κB) pathways.

1 April 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KDKris Simone T. Dias
Kris Simone T. Dias
CPCynthia T. de Paula
Cynthia T. de Paula
TSThiago dos Santos
Thiago dos Santos
ISIsis Nem de Oliveira Souza
Isis Nem de Oliveira Souza
MBMarina S. Boni
Marina S. Boni
CJClaudio Viegas Jr.
Claudio Viegas Jr.

7 January 2018 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
FMFabiana Morroni
Fabiana Morroni
GSGiulia Sita
Giulia Sita
ADAlice Djemil
Alice Djemil
MDMassimo D’aMico
Massimo D’aMico
Letizia PruccoliLetizia Pruccoli
Letizia Pruccoli
Andrea TarozziAndrea Tarozzi
Andrea Tarozzi

25 June 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
Letizia PruccoliLetizia Pruccoli
Letizia Pruccoli
FMFabiana Morroni
Fabiana Morroni
GSGiulia Sita
Giulia Sita
Patrizia HRELIAPatrizia HRELIA
Patrizia HRELIA
Andrea TarozziAndrea Tarozzi
Andrea Tarozzi
Oxidative stress (OS) appears to be an important determinant during the different stages of progression of Alzheimer’s Disease (AD). In particular, impaired antioxidant defense mechanisms, such as the decrease of glutathione (GSH) and nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2), a master regulator of antioxidant genes, including those for GSH, are associated with OS in the human AD brain. Among the neuropathological hallmarks of AD, the soluble oligomers of amyloid beta (A) peptides seem to promote neuronal death through mitochondrial dysfunction and OS. In this regard, bifunctional antioxidants can exert a dual neuroprotective role by scavenging reactive oxygen species (ROS) directly and concomitant induction of antioxidant genes. In this study, among natural coumarins (esculetin, scopoletin, fraxetin and daphnetin), we demonstrated the ability of esculetin (ESC) to prevent and counteract ROS formation in neuronal SH-SY5Y cells, suggesting its profile as a bifunctional antioxidant. In particular, ESC increased the resistance of the SH-SY5Y cells against OS through the activation of Nrf2 and increase of GSH. In similar experimental conditions, ESC could also protect the SH-SY5Y cells from the OS and neuronal death evoked by oligomers of A1–42 peptides. Further, the use of the inhibitors PD98059 and LY294002 also showed that Erk1/2 and Akt signaling pathways were involved in the neuroprotection mediated by ESC. These results encourage further research in AD models to explore the efficacy and safety profile of ESC as a novel neuroprotective agent.

1 March 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FVFlávia Pereira Dias Viegas
Flávia Pereira Dias Viegas
MSMatheus de Freitas Silva
Matheus de Freitas Silva
MRMiguel Divino da Rocha
Miguel Divino da Rocha
MCMaísa Rosa Castelli
Maísa Rosa Castelli
MRMariana Máximo Riquiel
Mariana Máximo Riquiel
CJClaudio Viegas Jr.
Claudio Viegas Jr.

1 January 2022 in Toxicology
Verified
Journal Article
Closed access
HCHericles Mesquita Campos
Hericles Mesquita Campos
MCMichael da Costa
Michael da Costa
LMLorrane Kelle da Silva Moreira
Lorrane Kelle da Silva Moreira
HNHiasmin Franciely da Silva Neri
Hiasmin Franciely da Silva Neri
CSCinthia Rio Branco da Silva
Cinthia Rio Branco da Silva
PGPaulo César Ghedini
Paulo César Ghedini